MYDGF and metabolic dysfunction-associated steatotic liver disease: Accordingly, serum MYDGF levels were 35.1% lower in NAFLD mice than in control mice, and the serum MYDGF level was also negatively correlated with the severity of NAFLD in mice with NAFLD (Fig. S1B and Table S2, P < 0.001).